VERMOX (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the VERMOX drug offered from Janssen Pharmaceuticals, Inc.. This Antihelminthic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | mebendazole |
SUBSTANCE NAME: | MEBENDAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antihelminthic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-10-20 |
END MARKETING DATE: | 0000-00-00 |
VERMOX HUMAN PRESCRIPTION DRUG Details:
Item Description | VERMOX from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2016-10-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-675_086f72d0-a9b6-46ea-ac0d-53a4999fa3a2 |
PRODUCT NDC: | 50458-675 |
APPLICATION NUMBER: | NDA208398 |
Other MEBENDAZOLE Pharmaceutical Manufacturers / Labelers: